Treating Cancer With Precision Its Time For Host Response Profiling - Latest News

Treating cancer with precision: It’s time for host response profiling

Within the cancer care community, precision ... treatment. One of the top questions facing researchers in the field today is “who will respond best to immunotherapy?” Enter Host Response ... read more

Add your link right here

Add your story here to improve SEO, search ranking and drive traffic to your website. Your link will be permanently featured right on this page. To add a link on diferent page, just visit the page you want to show your link and click "Add your link right here". You can use search form below to find the page. read more

OncoHost raises $8 million to develop AI that predicts cancer treatment responses

OncoHost, a startup developing an AI platform to predict cancer treatment responses and identify drug targets, has raised $8 million. read more

OncoHost Secures $8 Million Series B Funding Round

OncoHost, a global leader in technology involving host response profiling and personalized cancer therapy, has completed a $8 million Series B funding round. The new funding will help advance the ... read more

OncoHost Secures $8 Million Series B Funding Round to Advance its AI-Powered Precision Oncology Platform

OncoHost, global leader in host response profiling for improved personalized cancer therapy, today announced the completion of a $8 ... read more

OncoHost Secures $8M in Series B Funding

OncoHost, a Binyamina, Israel-based leader in host response profiling for improved personalized cancer therapy, completed an $8m Series B funding round ... read more

Israeli Startup OncoHost Raises $8M For AI Precision Oncology Platform

OncoHost developed a platform to identify key biological processes and proteins that drive response in patients undergoing cancer treatment. read more

First Head & Neck Cancer Patient Treated in France in a Phase I Trial With TG4050 (myvac Platform), Transgenes Innovative Individualized Immunotherapy

Transgene (Paris:TNG) (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, today announces that a first patient with head and neck cancer ... read more

Nobel prizewinner Ciechanover hails ‘much more precise’ cancer treatment

“The idea is to predict ahead of time ... treatment. “Proteomic analysis is allowing us to make great advances in personalized cancer care. With OncoHost’s host response profiling platform ... read more

OncoHost Welcomes Nobel Prize Winner to Scientific Advisory Board

OncoHost, global leader in host response profiling for improved personalized cancer therapy, announced today that renowned biologist and winner of The Nobel Prize in Chemistry, Professor Aaron ... read more